FDA approves Donanemab, Eli Lilly’s new drug for early Alzheimer’s diseaseBy KnowledgeHippoJuly 3, 2024 The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a new class…
Alzheimer’s researcher accused of fraudBy KnowledgeHippoJuly 2, 2024 A scientist whose research was at the center of controversy over an Alzheimer’s drug candidate has been charged with fraud.A…
Seemingly healthy, but diagnosed with Alzheimer’s?By KnowledgeHippoMarch 5, 2024 Determining whether someone has Alzheimer’s usually requires an extensive diagnostic process. A doctor takes a patient’s medical history, discusses symptoms,…
